Navigation Links
CSC Cited as a Leading Technology Provider in Celent Insurance Software Study

FALLS CHURCH, Va., July 7 /PRNewswire/ -- CSC (NYSE: CSC) today announced that it has been named a leading technology provider in multiple categories of Celent's 2009 Insurance Software Deal Trends study, published in two editions. Celent, a financial services technology research and advisory firm, reported in the Life/Health Edition that CSC is the leader in Life, Health and Annuity Core Processing with 56 percent of the deals in 2007 and 2008, as well as a leader in Life, Health and Annuity Infrastructure and Accounting. In addition, Celent identified CSC in the Property/Casualty Edition as a leader in Property and Casualty (P&C) Core Processing and P&C Distribution.


Celent's 2009 Insurance Software Deal Trends study ranks technology companies based on number of contracts signed in 2007 and 2008 and collected data on 1,315 deals with carriers.

In the same reports, CSC was named a "Traction Index" leader, placing in the top 10. The Traction Index is a composite measure that considers the type and size of deals, and the size of a vendor's clients.

"We would like to extend our congratulations to CSC for its leadership in multiple categories," said Craig Weber, senior vice president of the Celent insurance practice. "We believe that carriers value partners who know the insurance vertical well, and who demonstrate their commitment to it. It's not surprising that CSC is a leader in these categories, as its product breadth, technology innovation and long history in the vertical are attractive to new and returning clients."

"Celent's continued recognition of CSC's leadership in the insurance industry is a great honor and a testament to our long-standing commitment to helping our clients achieve success," said Jim Cook, president of CSC's Business Solutions and Services Sector. "For more than 30 years, CSC's mission-critical software, comprehensive back-office services and global IT infrastructure have helped insurers reduce costs and improve productivity."

The Deal Trends reports provide readers with a snapshot of leading software vendors. They were written as independent reports for Celent's insurance research subscribers and were not sponsored or directed by CSC or any other company. For more information on the reports, visit and

About CSC

CSC is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions and Services, the Managed Services Sector and the North American Public Sector. CSC's advanced capabilities include systems design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting. Headquartered in Falls Church, Va., CSC has approximately 92,000 employees and reported revenue of $16.74 billion for the 12 months ended April 3, 2009. For more information, visit the company's Web site at

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Ward Cited for Support of Wounded Warrior Project
2. Federal funding gap cited for research on human health impacts due to climate change
3. Applying the Obama Test to Healthcare: SimplyWell Cited as Top 10 Best Practices by Center for Healthcare Transformation
4. Global Med Technologies(R) Inc. Receives Unsolicited Proposal From Victory Park Capital Advisors, LLC
5. Forest Laboratories Responds To Unsolicited Mini-Tender Offer
6. Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle
7. Endocare Comments on Unsolicited Proposal
8. Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications
9. Ohio congresswoman cited by American College of Physicians
10. Providing Affordable Health Care Coverage Cited as a Top Priority, Commissioner Says
11. Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: